CEO · Founder, HealthMatch
Stories naming Manuri Gunawardena. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney clinical trials platform HealthMatch raised a $10 million Series C led by Folklore Ventures with Square Peg participating, after laying off half its staff in June; funds will support rehiring and US expansion.
Also SmartCompany·Techboard
Square Peg's retrospective of 2019: five new portfolio companies, several large rounds it led or co-led, two acquisitions, two IPOs, new team members, and its capital deployed across new and follow-on deals.
Also TechCrunch Venture·SmartCompany·Startup Daily·Square Peg Capital portfolio·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·@AuManufacturing·StrictlyVC·Startup News (WA)·Australian FinTech·Australian FinTech·@AuManufacturing·TechCrunch Venture·TechCrunch Venture·Crunchbase News
Square Peg's investment note recounts co-leading HealthMatch's $6 million Series A after an accelerated five-day process, profiling founder Manuri Gunawardena's clinical trial matching platform and existing backer Tempus Partners.
Also Square Peg Capital portfolio·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Women's Agenda
Profile of HealthMatch founder and chief executive Manuri Gunawardena, covering the patient-trial matching platform's investor backing and her win at Veuve Clicquot's Bold Future Award.
Square Peg Capital recaps 2020: eight new investments including Zeller and HealthMatch, a US$450 million fourth fund close, follow-ons, new hires across Sydney, Singapore and Israel, and portfolio updates.
Also Square Peg Capital portfolio·Square Peg Capital portfolio·SmartCompany·Australian FinTech·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Women's Agenda·Australian FinTech·Crunchbase News·TechCrunch Venture
A roundup profiling ten Australian startups expected to grow in 2021, reporting raises by VAPAR, HealthMatch, Ovira, Heaps Normal, Vop and Outland Denim, plus grants, accelerator alumni and founders' plans.
Clinical trials matching startup HealthMatch, founded by a UNSW medical student, has closed a $6 million Series A led by Square Peg Capital and Tempus Partners, with Paul Bassat joining its board and a Roche partnership announced.
Also SmartCompany
Folklore Ventures founder story recalling its seed backing of Manuri Gunawardena's clinical trial matching startup HealthMatch, plus follow-ons in its Series A and December 2020 Series B alongside Square Peg.